Aperio Group’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-44,524
| Closed | -$2.34M | – | 2476 |
|
|
2020
Q3 | $2.34M | Buy |
44,524
+4,730
| +12% | +$248K | 0.01% | 1045 |
|
|
2020
Q2 | $1.32M | Buy |
39,794
+3,478
| +10% | +$116K | ﹤0.01% | 1288 |
|
|
2020
Q1 | $988K | Buy |
36,316
+7,459
| +26% | +$203K | ﹤0.01% | 1316 |
|
|
2019
Q4 | $569K | Buy |
28,857
+389
| +1% | +$7.67K | ﹤0.01% | 1731 |
|
|
2019
Q3 | $369K | Buy |
28,468
+5,100
| +22% | +$66.1K | ﹤0.01% | 1920 |
|
|
2019
Q2 | $291K | Sell |
23,368
-434
| -2% | -$5.41K | ﹤0.01% | 2037 |
|
|
2019
Q1 | $346K | Buy |
23,802
+1,354
| +6% | +$19.7K | ﹤0.01% | 1939 |
|
|
2018
Q4 | $248K | Sell |
22,448
-836
| -4% | -$9.24K | ﹤0.01% | 2035 |
|
|
2018
Q3 | $612K | Buy |
23,284
+1,913
| +9% | +$50.3K | ﹤0.01% | 1662 |
|
|
2018
Q2 | $437K | Buy |
21,371
+3,102
| +17% | +$63.4K | ﹤0.01% | 1808 |
|
|
2018
Q1 | $332K | Buy |
18,269
+1,202
| +7% | +$21.8K | ﹤0.01% | 1900 |
|
|
2017
Q4 | $238K | Sell |
17,067
-773
| -4% | -$10.8K | ﹤0.01% | 2071 |
|
|
2017
Q3 | $330K | Sell |
17,840
-311
| -2% | -$5.75K | ﹤0.01% | 1869 |
|
|
2017
Q2 | $307K | Buy |
18,151
+1,562
| +9% | +$26.4K | ﹤0.01% | 1883 |
|
|
2017
Q1 | $221K | Sell |
16,589
-667
| -4% | -$8.89K | ﹤0.01% | 1994 |
|
|
2016
Q4 | $260K | Buy |
17,256
+865
| +5% | +$13K | ﹤0.01% | 1862 |
|
|
2016
Q3 | $192K | Buy |
16,391
+2,224
| +16% | +$26.1K | ﹤0.01% | 1952 |
|
|
2016
Q2 | $153K | Buy |
+14,167
| New | +$153K | ﹤0.01% | 1925 |
|
|
2016
Q1 | – | Sell |
-11,509
| Closed | -$171K | – | 2079 |
|
|
2015
Q4 | $171K | Buy |
11,509
+1,484
| +15% | +$22K | ﹤0.01% | 1854 |
|
|
2015
Q3 | $165K | Buy |
10,025
+1,129
| +13% | +$18.6K | ﹤0.01% | 1791 |
|
|
2015
Q2 | $203K | Buy |
+8,896
| New | +$203K | ﹤0.01% | 1860 |
|